Comment on 'Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: A multicentre, prospective, cluster randomised, crossover clinical trial'

Int J Antimicrob Agents. 2023 Aug;62(2):106853. doi: 10.1016/j.ijantimicag.2023.106853. Epub 2023 May 18.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Multicenter Study
  • Letter
  • Comment

MeSH terms

  • Antifungal Agents / therapeutic use
  • Aspergillosis* / drug therapy
  • Drug Monitoring
  • Humans
  • Invasive Fungal Infections* / drug therapy
  • Prospective Studies
  • Voriconazole / therapeutic use

Substances

  • Voriconazole
  • Antifungal Agents